Luke Timmerman
Seattle-based Cardeas Pharma, a startup led by prominent biotech entrepreneur A. Bruce Montgomery, has raised its first $1 million, according to a regulatory filing. The company only lists two executives and members of its board—Montgomery and Melissa Yaeger, an experienced drug developer who previously worked with Montgomery at Seattle-based Corus Pharma and Gilead Sciences. Montgomery, who left his role as a senior vice president at Gilead in August, hasn’t yet talked publicly about what Cardeas is setting out to do.
